Reviva Pharmaceuticals Holdings's total assets for Q3 2025 were $14.33M, an increase of 23.19% from the previous quarter. RVPH total liabilities were $9.78M for the fiscal quarter, a -19.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.